PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set

Maja B Drakenberg Danese, Christoffer P Vannas, Henrik A Fagman, Per O Karlsson, Karolina F Larsson

Open source

DOI
10.2340/1651-226x.2026.45589
Published
2026-05-11
Container
Acta Oncologica
Publisher
MJS Publishing, Medical Journals Sweden AB
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2340/1651-226x.2026.45589,
  title = {PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set},
  author = {Maja B Drakenberg Danese and Christoffer P Vannas and Henrik A Fagman and Per O Karlsson and Karolina F Larsson},
  year = {2026},
  journal = {Acta Oncologica},
  doi = {10.2340/1651-226x.2026.45589},
  url = {https://doi.org/10.2340/1651-226x.2026.45589}
}

RIS

TY  - JOUR
TI  - PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set
AU  - Maja B Drakenberg Danese
AU  - Christoffer P Vannas
AU  - Henrik A Fagman
AU  - Per O Karlsson
AU  - Karolina F Larsson
PY  - 2026
JO  - Acta Oncologica
DO  - 10.2340/1651-226x.2026.45589
UR  - https://doi.org/10.2340/1651-226x.2026.45589
ER  - 

APA

Danese, M. B. D., Vannas, C. P., Fagman, H. A., Karlsson, P. O., & Larsson, K. F. (2026). PIK3CA mutation testing and alpelisib use in metastatic breast cancer: a real-world data set. Acta Oncologica. https://doi.org/10.2340/1651-226x.2026.45589

Source records